Santilli Luca, Canovari Benedetta, Balducci Maria, Ginevri Francesco, Maracci Monia, Polenta Antonio, Anzalone Norma, Franca Lucia, Mariotti Beatrice, Sterza Lucia, Barchiesi Francesco
Unit of Infection Diseases, San Salvatore Hospital, Azienda Sanitaria Territoriale Pesaro e Urbino, CAP 61121 Pesaro, Italy.
Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, CAP 60126 Ancona, Italy.
Infect Dis Rep. 2025 May 2;17(3):46. doi: 10.3390/idr17030046.
The appearance of new clinical manifestations (for example, subcutaneous or skin abscesses) during anti-tuberculosis treatment is generally indicative of therapeutic failure. The cause of therapeutic failure may be the presence of a drug-resistant infection or to the failure to achieve a sufficient concentration of the drugs in the bloodstream. Here, we report the case of a 25-year-old man suffering from tuberculosis infection with lymph-node and pulmonary involvement and an atypical response to specific therapy. Two weeks after starting four-drug antitubercular treatment, the patient began to experience fever, pain and functional impotence in the left foot and ankle, with subsequent evidence of ankle and tarsal osteomyelitis. Four weeks after starting treatment, the patient presented with several widespread, painful subcutaneous abscesses on the trunk, back and right lower limb. Drainage was performed from the ankle and from one of the abscesses, and polymerase chain reaction (PCR) showed a positive result for in both samples, with the absence of resistance to drugs. Anti-tubercular medications were continued, with resolution of the pulmonary and bone involvement but with persistence of subcutaneous abscesses, although subsequent drainages showed the absence of mycobacterium tuberculosis. We describe an unusual presentation of paradoxical reaction in the form of osteomyelitis and subcutaneous abscesses in an immunocompetent TB patient, and we reported other similar cases of paradoxical reactions described in the literature in the last ten years, which demonstrate the importance of considering paradoxical reactions in patients who present with new or worsening signs and symptoms after starting tuberculosis treatment.
抗结核治疗期间出现新的临床表现(例如皮下或皮肤脓肿)通常表明治疗失败。治疗失败的原因可能是存在耐药感染,或者是未能在血液中达到足够的药物浓度。在此,我们报告一例25岁男性患者,患有淋巴结和肺部受累的结核感染,对特定治疗有非典型反应。在开始四联抗结核治疗两周后,患者开始出现左脚和脚踝发热、疼痛及功能障碍,随后有踝关节和跗骨骨髓炎的证据。治疗开始四周后,患者在躯干、背部和右下肢出现多处广泛的疼痛性皮下脓肿。对踝关节和其中一个脓肿进行了引流,聚合酶链反应(PCR)在两个样本中均显示阳性结果,且无耐药情况。继续使用抗结核药物,肺部和骨骼病变有所缓解,但皮下脓肿持续存在,尽管随后的引流显示未检出结核分枝杆菌。我们描述了一例免疫功能正常的结核病患者以骨髓炎和皮下脓肿形式出现的反常反应的不寻常表现,并报告了过去十年文献中描述的其他类似反常反应病例,这表明在开始抗结核治疗后出现新的或恶化的体征和症状的患者中考虑反常反应的重要性。